SCHEMBL6718871

SCHEMBL6718871

NC(=O)C#Cc1ccc2occc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.53
CTNNB1 P35222 7/20 0.43
WNT3A P56704 7/20 0.43
PLAU P00749 1/20 0.40
AR P10275 1/20 0.39
HTR1B P28222 1/20 0.39
DYRK1A Q13627 2/20 0.38
CDK9 P50750 1/20 0.38
EPM2A O95278 1/20 0.38
PTPRC P08575 1/20 0.38
PTPN6 P29350 1/20 0.38
CDC14A Q9UNH5 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
KMO O15229 1/20 0.38
CHRNA1 P02708 2/20 0.37
CHRNG P07510 2/20 0.37
CHRNB1 P11230 2/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96127 0.73 CYP2A6 (0.66) CYP2A6CTNNB1WNT3AHTR1BDYRK1A
SCHEMBL3441414 0.70 AR (0.61) CYP2A6CTNNB1WNT3AARHTR1B
SCHEMBL29968261 0.70 CYP2A6 (1.00) CYP2A6HTR1BDYRK1ACDK9EPM2A
SCHEMBL827799 0.70 CYP2A6 (1.00) CYP2A6HTR1BDYRK1ACDK9EPM2A
SCHEMBL15441267 0.70 CYP2A6 (0.66) CYP2A6CTNNB1WNT3AHTR1BDYRK1A
SCHEMBL16367840 0.67 PRSS1 (0.38)
SCHEMBL5809234 0.67 CTNNB1 (0.48) CYP2A6CTNNB1WNT3AHTR1BEPM2A
Hydrochloric Acid SCHEMBL2822366 0.66 CTNNB1 (0.63) CYP2A6CTNNB1WNT3AARHTR1B
SCHEMBL5204866 0.66 ALDH1A1 (0.46) CTNNB1WNT3AHTR3A
SCHEMBL11242597 0.66 HTR1B (0.43) CYP2A6CTNNB1WNT3APLAUAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077557-A1 Macrolide antibiotics GLAXO GROUP LIMITED (GB) 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077557-A1 Macrolide antibiotics MALT1, MRPL21, IL1R1 CYP2A6 562/4885CTNNB1 3280/4885WNT3A 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.